Is a complete ETR/1SXP research report available?

No complete published report is available for etr/1SXP (ETR/1SXP) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

etr/1SXP stock profile: metrics, valuation and analysis

Market cap	3.5B
Revenue (ttm)	1B
Net income (ttm)	136.2M
EPS (ttm)	€0.90
Shares out	150.6M
P/E (trailing)	25.6x
P/E (forward)	19.4x
Dividend	€0.18 (0.77%)
Volume	65,141
Beta	0.99

All ETR/1SXP indicators

Market & fundamental data

Available fields

212

Groups with data

Currency

EUR

Showing 212 of 212 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	DE
Employees	5,002
Employees Change	227%
Employees Change Percent	4.75
Enterprise value	EUR 3.8B
Exchange	Deutsche Börse Xetra
Financial currency	EUR
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Industry PE	60.32
Industry PE Fwd	23.24
Isin	DE000A3ENQ51
Last refreshed	2026-09-12
Market cap	EUR 3.5B
Price	EUR 23.15
Price currency	EUR
Rev Per Employee	203,279.69x
Sector	Healthcare
Sector PE	37.53
Sector PE Fwd	14.15
Sic	3221
Symbol	etr/1SXP
Website	https://www.schott-pharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.92%
EV Earnings	27.58x
EV/EBIT	20.49x
EV/EBITDA	13.86x
EV/FCF	68.09x
EV/Sales	3.7x
FCF yield	1.59%
Forward P/E	19.38x
P/B ratio	3.48x
P/E ratio	25.62x
P/S ratio	3.41x
PE Ratio3 Y	26.71x
PEG ratio	2.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	16.45%
EBITDA Margin	24.52%
FCF margin	5.43%
Gross margin	31.17%
Gross Profit	EUR 316.9M
Gross Profit Growth	-3.82%
Gross Profit Growth Q	-9.97%
Gross Profit Growth3 Y	1.27%
Net Income	EUR 136.2M
Net Income Growth	-7.48%
Net Income Growth Q	-14.53%
Net Income Growth Qo Q	25.2%
Net Income Growth3 Y	-1.54%
Pretax Margin	17.21%
Profit Margin	13.4%
Profit Per Employee	EUR 27,233
ROA	6.49
Roa5y	9.37
ROCE	13.43
ROE	14.67
Roe5y	21.86
ROIC	10.46
Roic5y	17.21

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	10.32%
EPS Growth	-7.25
EPS Growth Q	-13.33
EPS Growth Qo Q	23.81
EPS Growth3 Y	-1.78
FCF Growth	11.11%
FCF Growth Q	-22.51%
FCF Growth Qo Q	-79.59%
FCF Growth3 Y	-8.61%
OCF Growth	-5.04%
OCF Growth Q	-17.3%
OCF Growth Qo Q	-50.28%
OCF Growth3 Y	-3.88%
Revenue Growth	4.15x
Revenue Growth Q	9.99x
Revenue Growth Qo Q	13.67x
Revenue Growth3 Y	5.21x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.63
Assets	EUR 1.7B
Cash	EUR 24.9M
Current Assets	EUR 721.5M
Current Liabilities	EUR 449.2M
Debt	EUR 308.3M
Debt EBITDA	EUR 1.21
Debt Equity	EUR 0.31
Debt FCF	EUR 5.59
Equity	EUR 998.4M
Interest Coverage	10.08
Liabilities	EUR 696.1M
Long Term Assets	EUR 972.9M
Long Term Liabilities	EUR 246.9M
Net Cash	EUR -283.4M
Net Cash By Market Cap	EUR -8.16
Net Debt EBITDA	EUR 1.14
Net Debt Equity	EUR 0.28
Net Debt FCF	EUR 5.14
Tangible Book Value	EUR 965.3M
Tangible Book Value Per Share	EUR 6.46
WACC	9.23

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.61
Inventory Turnover	4.13
Net Working Capital	EUR 478.8M
Quick ratio	0.74
Working Capital	EUR 272.4M
Working Capital Turnover	EUR 4

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.12%
Dividend Growth	12.5%
Dividend Growth Years	1%
Dividend per share	EUR 0.18
Dividend Years	3
Dividend Yield	0.77%
Ex Div Date	2026-02-04
Last Dividend	EUR 0.18
Payout Frequency	Annual
Payout Ratio	19.9%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	10.32%
200-day SMA	17.04
50-day SMA	21.78
50-day SMA vs 200-day SMA	50over200
All Time High	43.4
All Time High Change	-46.66%
All Time High Date	2024-02-29
All Time Low	12.62
All Time Low Change	83.44%
All Time Low Date	2026-03-23
ATR	0.62
Beta	0.99
Beta1y	0.85
Beta2y	0.96
Ch YTD	53.31
High	23.55
High52	23.75
High52 Date	2026-08-28
High52ch	-2.53%
Low	23.15
Low52	12.62
Low52 Date	2026-03-23
Low52ch	83.44%
Ma50ch	6.31%
Price vs 200-day SMA	35.89%
RSI	56.29
RSI Monthly	50.88
RSI Weekly	68.76
Sharpe ratio	0.33x
Sortino ratio	0.68
Total Return	0.89%
Tr YTD	55.25
Tr1m	3.81%
Tr1w	0.43%
Tr3m	32.29%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	34,641,362%
Net Borrowing	12,878,000
Shares Institutions	18.99%
Shares Out	150,614,616
Shares Qo Q	1.12%
Shares Yo Y	-0.12%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	66,484.4x
Bv Per Share	6.67
CAPEX	EUR -137.7M
Ch1m	3.81
Ch1w	0.43
Ch1y	8.94
Ch3m	32.29
Ch6m	66.79
Change	-1.49%
Change From Open	-1.49
Close	23.5
Days Gap	0
Depreciation Amortization	82,072,000
Dollar Volume	1,508,014.2
Earnings Date	2026-12-10
EBIT	EUR 167.2M
EBITDA	EUR 249.3M
EPS	EUR 0.9
F Score	5
FCF	EUR 55.2M
FCF EV Yield	1.47x
FCF Per Share	EUR 0.37
Financing CF	-26,626,000
Fiscal Year End	September
Founded	1,884
Graham Number	11.6645
Graham Upside	-49.61
Income Tax	EUR 38.2M
Investing CF	-170,896,000
Is Primary Listing	1
Last Earnings Date	2026-08-12
Last Report Date	2026-06-30
Lynch Fair Value	EUR 4.54
Lynch Upside	-80.38
Ma150	17.56
Ma150ch	31.82%
Ma20	23.03
Ma20ch	0.53%
Net CF	-3,411,000
Next Earnings Date	2026-12-10
Open	23.5
P FCF Ratio	62.92
P OCF Ratio	18
Payment Date	2026-02-06
Position In Range	0
Ppne	832,508,000
Price Date	2026-09-10
Price EBITDA	EUR 13.93
Ptbv Ratio	3.6
Relative Volume	0.99x
Revenue	1,016,805,000x
Tax By Revenue	3.76x
Tax Rate	21.85%
Tr6m	66.79%
Volume	65,141
Z Score	3.78

ETR/1SXP (ETR/1SXP)

Price

Financial snapshot

Fair-value bridge

Latest news · ETR/1SXP

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ETR/1SXP indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on ETR/1SXP

Frequently asked questions